Halozyme Therapeutics Inc (HALO)
45.73
-0.03
(-0.07%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.09
(+0.20%)
After-Hours: 17:54
Halozyme Therapeutics Price to Book Value: 12.85 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 12.86 |
| November 19, 2024 | 12.59 |
| November 18, 2024 | 11.96 |
| November 15, 2024 | 12.83 |
| November 14, 2024 | 15.16 |
| November 13, 2024 | 16.47 |
| November 12, 2024 | 16.75 |
| November 11, 2024 | 17.17 |
| November 08, 2024 | 17.14 |
| November 07, 2024 | 16.76 |
| November 06, 2024 | 17.04 |
| November 05, 2024 | 16.50 |
| November 04, 2024 | 16.43 |
| November 01, 2024 | 16.06 |
| October 31, 2024 | 14.21 |
| October 30, 2024 | 14.22 |
| October 29, 2024 | 14.23 |
| October 28, 2024 | 14.18 |
| October 25, 2024 | 13.84 |
| October 24, 2024 | 13.86 |
| October 23, 2024 | 14.27 |
| October 22, 2024 | 14.48 |
| October 21, 2024 | 14.54 |
| October 18, 2024 | 14.78 |
| October 17, 2024 | 14.69 |
| Date | Value |
|---|---|
| October 16, 2024 | 15.02 |
| October 15, 2024 | 15.12 |
| October 14, 2024 | 15.16 |
| October 11, 2024 | 14.89 |
| October 10, 2024 | 14.65 |
| October 09, 2024 | 14.23 |
| October 08, 2024 | 15.21 |
| October 07, 2024 | 15.13 |
| October 04, 2024 | 16.63 |
| October 03, 2024 | 16.98 |
| October 02, 2024 | 16.34 |
| October 01, 2024 | 15.91 |
| September 30, 2024 | 16.08 |
| September 27, 2024 | 24.94 |
| September 26, 2024 | 24.93 |
| September 25, 2024 | 24.45 |
| September 24, 2024 | 24.60 |
| September 23, 2024 | 25.62 |
| September 20, 2024 | 25.93 |
| September 19, 2024 | 26.04 |
| September 18, 2024 | 27.27 |
| September 17, 2024 | 27.11 |
| September 16, 2024 | 27.54 |
| September 13, 2024 | 27.27 |
| September 12, 2024 | 26.50 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
10.65
Minimum
Dec 30 2019
108.84
Maximum
Apr 29 2021
39.80
Average
35.97
Median
Jul 07 2020
Price to Book Value Benchmarks
| Abbott Laboratories | 5.111 |
| Novavax Inc | -- |
| Insulet Corp | 16.44 |
| BioLife Solutions Inc | 3.620 |
| TransMedics Group Inc | 12.68 |
Price to Book Value Related Metrics
| PE Ratio | 15.14 |
| PS Ratio | 6.267 |
| PEG Ratio | 0.2497 |
| Price to Free Cash Flow | 15.12 |
| Price | 45.73 |
| Earnings Yield | 6.60% |
| Market Cap | 5.818B |
| PEGY Ratio | 0.2497 |
| Operating PE Ratio | 12.45 |
| Normalized PE Ratio | 15.87 |